Aditxt, Inc.
ADTXNASDAQHealthcare● Active
$0.05
$-0.01(-19.65%)
Market Cap$1672
P/E Ratio—
52W High$53453.52
52W Low$0.0463
Aditxt, Inc. (ADTX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ADTX · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 20, 2026EPS Actual
-$2.06
Est. -$2245536000.00 · +100.0%
Revenue
$0.00B
Est. $0.00B · -98.8%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 20, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue🔥 8-Quarter EPS Beat Streak
ADTX reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.09
Rev. $41.31B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.09
Rev. Est.$41.31B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 2, 2026 | -$24408000000.00 | — | — | — | $0.00B | — |
| ▲ Q2 FY2026 | May 20, 2026 | -$2245536000.00 | -$2.06 | +100.0% | $0.00B | $0.00B | -98.8% |
| ▲ Q1 FY2026 | Feb 25, 2026 | -$6443712.00 | -$1.48 | +100.0% | $0.00B | $0.00B | +0.0% |
| ▲ Q4 FY2025 | Nov 17, 2025 | -$247696.00 | -$5.85 | +100.0% | $0.00B | $0.00B | -99.8% |
| ▲ Q3 FY2025 | Aug 14, 2025 | -$243176.00 | -$31.36 | +100.0% | $0.00B | $0.00B | -99.7% |
| ▲ Q2 FY2025 | May 15, 2025 | -$301032.00 | -$73.82 | +100.0% | $0.00B | $0.00B | -99.7% |
| ▲ Q2 FY2025 | Apr 14, 2025 | -$2694824.00 | -$404088.00 | +85.0% | $0.00B | $0.00B | +120.6% |
| ▲ Q4 FY2024 | Nov 18, 2024 | -$361600.00 | -$252431.80 | +30.2% | $0.00B | $0.00B | -50.4% |
Q3 FY2026
Sep 2, 2026
EPS Actual
—
EPS Est.
-$24408000000.00
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 20, 2026Beat
EPS Actual
-$2.06
EPS Est.
-$2245536000.00
EPS Surpr.
+100.0%
Revenue
$0.00B
Q1 FY2026
Feb 25, 2026Beat
EPS Actual
-$1.48
EPS Est.
-$6443712.00
EPS Surpr.
+100.0%
Revenue
$0.00B
Q4 FY2025
Nov 17, 2025Beat
EPS Actual
-$5.85
EPS Est.
-$247696.00
EPS Surpr.
+100.0%
Revenue
$0.00B
Q3 FY2025
Aug 14, 2025Beat
EPS Actual
-$31.36
EPS Est.
-$243176.00
EPS Surpr.
+100.0%
Revenue
$0.00B
Q2 FY2025
May 15, 2025Beat
EPS Actual
-$73.82
EPS Est.
-$301032.00
EPS Surpr.
+100.0%
Revenue
$0.00B
Q2 FY2025
Apr 14, 2025Beat
EPS Actual
-$404088.00
EPS Est.
-$2694824.00
EPS Surpr.
+85.0%
Revenue
$0.00B
Q4 FY2024
Nov 18, 2024Beat
EPS Actual
-$252431.80
EPS Est.
-$361600.00
EPS Surpr.
+30.2%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2029 | $-644371200.00 | $-644371200.00 | $-644371200.00 | 1 |
| Q3 FY2029 | $-668779200.00 | $-668779200.00 | $-668779200.00 | 1 |
| Q2 FY2029 | $-656575200.00 | $-656575200.00 | $-656575200.00 | 1 |
| Q1 FY2029 | $-812786400.00 | $-812786400.00 | $-812786400.00 | 1 |
| Q4 FY2028 | $-7276024800.00 | $-7276024800.00 | $-7276024800.00 | 1 |
| Q3 FY2028 | $-976320000.00 | $-976320000.00 | $-976320000.00 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 20, 2026 | +100.0% | $1.52 | $1.40 | -7.89% |
| ▲ Q1 FY2026 | Feb 25, 2026 | +100.0% | $112.05 | $109.35 | -2.41% |
| ▲ Q4 FY2025 | Nov 17, 2025 | +100.0% | $1,045.44 | $915.84 | -12.40% |
| ▲ Q3 FY2025 | Aug 14, 2025 | +100.0% | $25,628.40 | $25,140.24 | -1.90% |
| ▲ Q2 FY2025 | May 15, 2025 | +100.0% | $40,517.28 | $39,296.88 | -3.01% |
| ▲ Q2 FY2025 | Apr 14, 2025 | +85.0% | $70,295.04 | $61,020.00 | -13.19% |
| ▲ Q4 FY2024 | Nov 18, 2024 | +30.2% | $1,970,946.00 | $2,068,578.00 | +4.95% |
| ▲ Q3 FY2024 | Aug 19, 2024 | +100.0% | $283,132,800.00 | $278,251,200.00 | -1.72% |
Q2 FY2026-7.89%
Report Date
May 20, 2026
EPS Beat/Miss
+100.0%
Price Before
$1.52
Price After
$1.40
Q1 FY2026-2.41%
Report Date
Feb 25, 2026
EPS Beat/Miss
+100.0%
Price Before
$112.05
Price After
$109.35
Q4 FY2025-12.40%
Report Date
Nov 17, 2025
EPS Beat/Miss
+100.0%
Price Before
$1,045.44
Price After
$915.84
Q3 FY2025-1.90%
Report Date
Aug 14, 2025
EPS Beat/Miss
+100.0%
Price Before
$25,628.40
Price After
$25,140.24
Q2 FY2025-3.01%
Report Date
May 15, 2025
EPS Beat/Miss
+100.0%
Price Before
$40,517.28
Price After
$39,296.88
Q2 FY2025-13.19%
Report Date
Apr 14, 2025
EPS Beat/Miss
+85.0%
Price Before
$70,295.04
Price After
$61,020.00
Q4 FY2024+4.95%
Report Date
Nov 18, 2024
EPS Beat/Miss
+30.2%
Price Before
$1,970,946.00
Price After
$2,068,578.00
Q3 FY2024-1.72%
Report Date
Aug 19, 2024
EPS Beat/Miss
+100.0%
Price Before
$283,132,800.00
Price After
$278,251,200.00
Avg Beat Reaction-4.70%
Beat Rate8 / 8 quarters
Largest Move-13.19% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ADTX ends December
Aditxt, Inc. (ADTX) most recently reported earnings on May 20, 2026 for Q2 FY2026, posting EPS of $-2.06 — beating the analyst consensus of $-2245536000.00 by +100.0%. ADTX has beaten EPS estimates for 8 consecutive quarters. The next ADTX earnings date is expected around September 1, 2026.
Each quarter, investors track ADTX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ADTX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ADTX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ADTX earnings · 5 questionsAditxt, Inc.'s next earnings report is expected around September 1, 2026. ADTX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ADTX historically reports after market close (AMC).
ADTX earnings datewhen is ADTX earningsADTX next earnings datewhen does ADTX report earningsADTX earnings calendar
▸ Source: FMP · Aditxt, Inc. SEC filings · US GAAP · Aditxt, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026